Samia Shahnawaz
About Samia Shahnawaz
Samia Shahnawaz is a Regulatory Specialist at NYU Langone Health and Vice President at Mission for Mental Health, with extensive experience in clinical trial management and regulatory affairs.
Current Roles and Responsibilities
Samia Shahnawaz currently holds multiple positions within the healthcare sector. She serves as a Regulatory Specialist at NYU Langone Health, focusing on interim monitoring visits and study closure visits. Additionally, she manages all Institutional Review Board (IRB) related activities including amendments, annual continuations, and study closures for clinical trials. Parallelly, she holds the position of Vice President at Mission for Mental Health, and works as a Branch Editor at Polygeia, both roles based in New York.
Previous Positions and Experiences
Before her current roles, Samia Shahnawaz worked as a Regulatory Assistant at NYU Langone Health from 2020 to 2021. She also served as a Senior Patient Coordinator at Weill Cornell Medicine, specifically in the Office of Dr. Kevin Holcomb GYN Oncology from 2018 to 2020. Her earlier experiences include working as a Pathos Editor and Intern at The Humanology Project, and as a Student Assistant at Stony Brook University.
Educational Background
Samia Shahnawaz has a solid educational foundation in health and sciences. She obtained a Master of Public Health (MPH) in Biostatistics from New York University. She also completed a Post-Baccalaureate in Pre-Medicine/Pre-Medical Studies from the University of North Carolina at Greensboro. Her undergraduate education includes a Bachelor's Degree in Psychology from Stony Brook University. She completed her high school education at Grimsley High School.
Key Responsibilities and Skills
In her role at NYU Langone Health, Samia Shahnawaz serves as the primary contact for all interim monitoring visits and study closure visits. She handles all IRB Amendments, Annual Continuation, and Study Closure submissions for clinical trials. Additionally, Samia provides weekly updates to Principal Investigators and study teams on IRB-approved amendments and upcoming changes. She is responsible for documenting all study staff training related to protocol amendments and updates, maintaining a strong knowledge of Good Clinical Practice (GCP) and guidelines related to consent, ethical conduct, and protection of human subjects.